Suchergebnisse - "Gu, Yong"

PubPharm (15)

1

Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease : A systematic review and meta-analysis

enthalten in: Journal of clinical pharmacy and therapeutics | 2020

von Gu, Y. | Pang, J. | Sun, Z. | +5

2

Expression levels and co‑targets of miRNA‑126‑3p and miRNA‑126‑5p in lung adenocarcinoma tissues : Αn exploration with RT‑qPCR, microarray and bioinformatic analyses

enthalten in: Oncology reports | 2019

von Chen, P. | Gu, Y. | Ma, F. | +7

3

Rs2227982 and rs2227981 in PDCD1 gene are functional SNPs associated with T1D risk in East Asian

enthalten in: Acta diabetologica | 2018

von Gu, Y. | Xiao, L. | Gu, W. | +11

4

CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function

enthalten in: Scientific reports | 2018

von Chen, Y. | Chen, S. | Gu, Y. | +13

5

Bioactive components of Chinese herbal medicine enhance endogenous neurogenesis in animal models of ischemic stroke : A systematic analysis

enthalten in: Medicine | 2016

von Li, J. | Chen, Z. | Zhang, X. | +7

6

Association between the PARP1 Val762Ala polymorphism and cancer risk : evidence from 43 studies

enthalten in: PloS one | 2014

von Hua, R. | Li, H. | Liang, Y. | +7

7

Evidence-based study of chromate exposed workers' health surveillance indexes

enthalten in: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine | 2013

von Gu, Y. | Qian, Q. | Yu, S. | +9

8

The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility : an updated meta-analysis

enthalten in: Asian Pacific journal of cancer prevention : APJCP | 2013

von Pan, Y. | Zhao, L. | Chen, X. | +3

9

Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy : a meta-analysis

enthalten in: Molecular biology reports | 2012

von Ding, W. | Wang, F. | Fang, Q. | +3

10

Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism : a meta-analysis

enthalten in: PloS one | 2012

von Zhang, Q. | Li, M. | You, L. | +5